Video
19 Jul 2023
Rapid Response to the European Food Safety Authority (EFSA) Ban on TiO2 as a Food Additive as it Relates to Film Coatings
This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. The session discusses:
Content provided by our supplier
Ashland Industries Europe GmbH
-
CH -
2015On CPHI since
-
1000 - 4999Employees
Company types
Other Content from Ashland Industries Europe GmbH (1)
-
News Ashland injectable pharmaceutical excipient accepted into FDA Novel Excipient Review Pilot Program
WILMINGTON, Del., Oct. 31, 2022 (GLOBE NEWSWIRE) announced the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research Office of New Drugs has accepted Ashland Viatel™ bioresorbable mPEG-PDLLA pharmaceutical excipient in the review cycle of the FDA Novel Excipient Review Pilot Program.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance